Atlas Trials

The Myocet/Lapatinib Study. ICORG 10-03, V5

Clinical trial NCT01495884 · TERMINATED

Trial details

NCT number
NCT01495884
Sponsor
Cancer Trials Ireland
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Her2 Positive Metastatic Breast Cancer
Start date
2011-03-01
Primary completion
2014-10-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.